Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes

NCT06959030 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Guangxi Medical University as lead sponsor.

NCT NCT06959030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06959030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes
Lead sponsor
Second Affiliated Hospital of Guangxi Medical University
Phase
Observational
Overall status
Recruiting
Start date
June 19, 2025
Completion date
September 1, 2026
Enrollment
10,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus (t2dm)